Ticker

Trulieve reported an increase in revenue, free cash flow, and lower debt for Q4 2025. The company received a provisional license to open medical dispensaries in Texas. The cannabis sector remains weak due to uncertainty over rescheduling.

The cannabis industry is always working its way uphill when it comes to any form of success. To be more specific, due to the legal landscape in most legal markets, sustaining profitability while staying consistent with quality products is a battle. For example, having the right machinery or setup to produce and expand on new and existing cannabis products continuously.

The U.S. marijuana industry continues to expand rapidly. More states are approving legal cannabis for medical and adult use. Consequently, investors are watching leading marijuana stocks closely this March. In addition, reform momentum in Washington could further unlock sector growth. As legalization conversations evolve, top operators may benefit from increased demand and market access. Below are the three…

Trulieve Cannabis Corp. (TCNNF) Q4 2025 Earnings Call Transcript

Full year revenue of $1.2 billion, with 60% gross margin Record 2025 cash flow from operations of $273 million and free cash flow of $229 million* Record 50.1 million branded product units sold in 2025, up 5% compared to last year TALLAHASSEE, Fla., Feb. 26, 2026 /PRNewswire/ -- Trulieve Cannabis Corp.